NCT01856764View on ClinicalTrials.gov

Topical Roflumilast in Adults With Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions

Atopic Dermatitis

Interventions

DRUG

0.5% Roflumilast Cream

Roflumilast 0.5% cream

DRUG

Vehicle Cream

Roflumilast formulation vehicle

Trial Locations (3)

Unknown

Berlin

Gera

Hamburg

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY